We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.2B
AUM Growth
+$19M
Cap. Flow
-$322M
Cap. Flow %
-1.45%
Top 10 Hldgs %
27.05%
Holding
698
New
75
Increased
150
Reduced
234
Closed
204

Top Buys

Rank Stock Value
1
PPG icon
PPG Industries
PPG
+$201M
2
BMY icon
Bristol-Myers Squibb
BMY
+$180M
3
AMZN icon
Amazon
AMZN
+$173M
4
CI icon
Cigna
CI
+$156M
5
BUD icon
AB InBev
BUD
+$137M

Top Sells

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$151M
2
MU icon
Micron Technology
MU
+$138M
3
AGN
Allergan plc
AGN
+$113M
4
NKE icon
Nike
NKE
+$96.8M
5
TOL icon
Toll Brothers
TOL
+$93.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.63%
2 Technology 17.55%
3 Consumer Discretionary 11.93%
4 Financials 11.1%
5 Communication Services 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POT
426
DELISTED
Potash Corp Of Saskatchewan
POT
$850K ﹤0.01%
27,450
WM icon
427
Waste Management
WM
$95.9B
$819K ﹤0.01%
17,675
-1,565
-8% -$78.7K
CVA
428
DELISTED
Covanta Holding Corporation
CVA
$798K ﹤0.01%
37,680
NVTA
429
DELISTED
Invitae Corporation
NVTA
$780K ﹤0.01%
+52,400
New +$746K
ONCE
430
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$774K ﹤0.01%
12,850
+3,350
+35% +$221K
LNC icon
431
Lincoln National
LNC
$7.91B
$767K ﹤0.01%
12,950
ARCT icon
432
Arcturus Therapeutics
ARCT
$157M
$760K ﹤0.01%
+16,600
New +$761K
OCUL icon
433
Ocular Therapeutix
OCUL
$1.86B
$743K ﹤0.01%
35,307
+5,650
+19% +$140K
PX
434
DELISTED
Praxair Inc
PX
$732K ﹤0.01%
6,125
SAP icon
435
SAP
SAP
$187B
$725K ﹤0.01%
10,330
-246,312
-96% -$18.3M
CHRS icon
436
Coherus Oncology
CHRS
$217M
$723K ﹤0.01%
+25,000
New +$632K
DERM
437
DELISTED
Dermira, Inc.
DERM
$702K ﹤0.01%
40,000
VCEL icon
438
Vericel Corp
VCEL
$2.3B
$700K ﹤0.01%
196,093
ITC
439
DELISTED
ITC HOLDINGS CORP
ITC
$700K ﹤0.01%
21,765
RVTY icon
440
Revvity
RVTY
$12.3B
$679K ﹤0.01%
12,900
-12,900
-50% -$673K
CRDF icon
441
Cardiff Oncology
CRDF
$64.3M
$671K ﹤0.01%
+918
New +$651K
AAC
442
DELISTED
AAC Holdings
AAC
$658K ﹤0.01%
+15,100
New +$555K
DUK icon
443
Duke Energy
DUK
$102B
$636K ﹤0.01%
9,010
NSC icon
444
Norfolk Southern
NSC
$78.8B
$631K ﹤0.01%
7,225
CLH icon
445
Clean Harbors
CLH
$16.1B
$620K ﹤0.01%
11,545
+1,055
+10% +$58.9K
BAP icon
446
Credicorp
BAP
$30.9B
$614K ﹤0.01%
4,422
-9,188
-68% -$1.34M
RDHL
447
Redhill Biopharma
RDHL
$3.85M
$610K ﹤0.01%
+35
New +$556K
MRK icon
448
Merck
MRK
$324B
$609K ﹤0.01%
11,219
XNPT
449
DELISTED
XENOPORT, INC.
XNPT
$606K ﹤0.01%
+98,850
New +$647K
ITUB icon
450
Itaú Unibanco
ITUB
$91.3B
$579K ﹤0.01%
131,849
+35,083
+36% +$165K

Similar funds

Fred Alger Management's Q2 2015 Portfolio in Review

As of Q2 2015, Fred Alger Management held 698 positions worth $22.2B, up 0.09% from $22.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Fred Alger Management's Q2 2015 filing shows 75 new, 150 increased, 234 reduced and 204 closed positions. Its largest new stake was Blackstone Mortgage Trust: 4,414,769 shares worth $123M. The largest sale was Hilton Worldwide, an estimated $151M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Fred Alger Management's largest Q2 2015 buy was Blackstone Mortgage Trust: 4,414,769 shares worth $123M.
  • Fred Alger Management added most to PPG Industries in Q2 2015, an estimated $201M increase.
  • Fred Alger Management's biggest Q2 2015 reduction was Hilton Worldwide, cutting an estimated $151M.
  • Fred Alger Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $57M.
  • Fred Alger Management's ten largest holdings make up 27% of its $22.2B portfolio in Q2 2015.
  • Fred Alger Management opened 75 new positions and closed 204 in Q2 2015.
  • Fred Alger Management's portfolio value rose 0.09% quarter-over-quarter to $22.2B.

Based on Fred Alger Management's 13F filing for Q2 2015, filed 14 Aug 2015.